| Literature DB >> 34918977 |
Haihua Gu1, Tianshu Liu1, Ling Zhu1, Lufeng Zhao1, Junqiang Fan1.
Abstract
Mediastinal unicentric Castleman disease (UCD) frequently manifests as a hyper-enhancing lymph node mass and is often surgically curable. However, because of excessive vascularisation and adhesion to important surrounding structures, surgery is often associated with severe haemorrhage that is often difficult to control thoracoscopically. Therefore, thoracotomy is often preferred, which increases the trauma to the patient and affects postoperative recovery. Here, we describe the case of a 30-year-old male patient with a large upper mediastinal lymph node (7 × 5 × 4 cm) that was compressing his superior vena cava. The distribution of nutritive arteries of the mass was analysed in detail, and the main branches were embolised prior to surgery. With the assistance of preoperative isovolumetric haemodilution, we achieved complete resection through single-port thoracoscopy, with only minor haemorrhage, which enabled the patient to recover rapidly. This multidisciplinary collaborative model, based on single-port thoracoscopic surgery, may be of wide practical use for the treatment of mediastinal UCD.Entities:
Keywords: Mediastinal mass; embolisation; lymph node; multidisciplinary treatment; nutritive artery; single port thoracoscopic surgery; thoracotomy; unicentric Castleman disease
Mesh:
Year: 2021 PMID: 34918977 PMCID: PMC8725231 DOI: 10.1177/03000605211062780
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Figure 1.Imaging manifestations, gross appearance and histology of the mass. (a and b) Computed tomography (CT) images demonstrating a homogenously enhanced, well-circumscribed mass that is compressing the superior vena cava (arrow). (c) CT-based three-dimensional reconstruction showing thick and tortuous blood vessels (arrow) around the mass. (d) Gross intraoperative appearance of the surgically excised mass. (e and f) Photomicrographs of haematoxylin and eosin-stained sections of the mass (100× and 400× respectively). The histologic architecture of the lymph node is almost destroyed, vascular proliferation and hyalinisation of the vessel walls are present, and in some areas, there are thickened mantle zones, lined by multiple layers of lymphocytes.
Figure 2.Contrast examination before and after embolisation of the nutritive vessels. (a) T3 intercostal artery; (b) T4 intercostal artery; (c) left thyrocervical trunk; (d) right internal thoracic artery.
Figure 3.Immunohistochemistry and in situ hybridisation (ISH) of sections of the mass. (a and b) CD20 and CD79α staining to indicate B cells. (c and d) CD3 and CD5 staining to indicate T cells. (e and f) Follicular dendritic cells stained with CD21 and CD23. (g) Ki-67 staining for active cell proliferation. Staining is principally in the germinal centres. (h) Immunostaining for HHV-8 was negative. (i) In situ hybridisation for the Epstein–Barr virus encoding region was negative. All 40× magnification.
Clinical findings, surgical details, and outcomes of previously reported cases of CD that were managed via thoracoscopy.
| Reference number | Mass location (size) | Surgical details | VATS ports | Pathology | Outcomes (follow-up period) |
|---|---|---|---|---|---|
|
| Most in the right or left upper mediastinum (range 1.9–6.5 cm) | Right or left VATS | At least 2 ports | HV (8), PC (2) | No recurrence (median 5 years) |
|
| Adherent to branches of the pulmonary artery and upper pulmonary vein (2.5 × 2.5 × 2 cm) | Right VATS converted to thoracotomy, with subsequent adjuvant radiotherapy | 3 trocars | HV | No recurrence (6 years) |
|
| Between the azygous vein and SVC (6 cm × 4 cm × 4 cm) | Right VATS | 3 ports | PC | No recurrence (5 years) |
|
| Left upper lobe (4.8 cm) | Left VATS | Not reported | HV | Not reported |
|
| Anterior mediastinum (4.5 cm ×2 cm) | Left VATS; the scope of resection included the anterior mediastinal fat tissue, thymus, the lesion, and the surrounding lymph nodes | 2 ports | PC | No recurrence (5 years) |
|
| Paratracheal, between the SVC and trachea (5 cm × 3 cm) | Right VATS | 2 ports | HV | No recurrence (5 years) |
|
| Mediastinum in 11 cases, hilum in 7 cases, and the lungs and mediastinum in 1 case (between 2 and 12 cm, mean: 5.8 cm) | 15 thoracotomy, 3 VATS, and 1 mediastinoscopy | Not reported | HV ( | 1 received postoperative radiotherapy (4 months), 1 was followed up by Medical oncology. 3 patients were lost to follow-up. Others were followed and developed no problems |
|
| Subcarinal (no value given) | Embolisation of the feeding vessels, VATS | Not reported | HV | No recurrence (1 year) |
|
| Around the intermediate and basal bronchi (5.0 × 4.8 cm) | Right VATS for right middle-lower lobectomy | Not reported | HV | No recurrence (8 months) |
|
| Between the azygous vein and oesophagus (5 × 3 × 2 cm) | Right VATS | 3 ports | HV | Not reported |
|
| Right cardiophrenic angle (6.0 × 4.5 × 3.4 cm) | Thoracoscopic procedure with minimal thoracotomy | Not reported | HV | Not reported |
|
| Pleura (from 3 to 10 cm, mean: 5.2 cm) | 4 thoracotomies, 2 VATS, 2 VATS converted to thoracotomy | Not reported | HV ( | Not reported |
|
| Right posterior mediastinum (5 × 5 × 3 cm) | Right VATS converted to thoracotomy | Not reported | HV | No recurrence (14 months) |
HV, hyaline vascular-type Castleman disease; PC, plasma cell-type Castleman disease; VATS, video-assisted thoracic surgery; SVC, superior vena cava.